Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
a loss of 20% therefore means that these people have lost almost 25 kg during the treatment and it is certain that losses of this magnitude, if maintained in the long term, will have positive effects on health
Functional Performance Profile Key Benefits Triple Agonist: GLP-1, GIP & Glucagon Advanced Weight Loss Muscle Preservation Metabolic Optimisation Improved Energy & Focus Product Specifications Purity: 99.8% Form: Lyophilized peptide Storage: 2-9C Refrigerated Research Information Type: Triple receptor agonist Pathways: GLP-1 / GIP / Glucagon Focus: Metabolic regulation Scientific Information Research Reference Parameters Laboratory Use Only Initial phase: 2-4 mg once weekly Standard research range: 5-8 mg once weekly Advanced research range: 8-12 mg once weekly Research cycles typically extend 8-16 weeks Mechanism of Action Retatrutide functions as a triple agonist: GIP activation enhances insulin secretion and fat metabolism
For CKD stages 35 (non-dialysis), the Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines typically recommend 0.550.60 g/kg/day (0.60.8 g/kg in diabetes)
Versatile & Neutral Taste Blends seamlessly into shakes, smoothies, and recipes without altering flavour, perfect for daily use
US$ 28.81
US$ 24.34
US$ 26.65
US$ 29.57
